Oslo, October 31, 2023) Medistim ASA (OSE: MEDI) is a niche market leader in
ultrasound technology, headquartered in Oslo, Norway. The company develops and
commercializes medical equipment for use in Cardiac, Vascular, and Transplant
surgery. Today, Medistim announce that they are expanding their market coverage
in Sweden by establishing a direct sales office, opening today. This move is
part
of the company's ongoing commitment to providing exceptional service to
customers as well as fulfilling the company's global growth strategy.

The company is well positioned to continue its growth by further developing the
conversion from devices with Transit Time Flow Measurement (TTFM) technology
only, to devices combining TTFM and High-Frequency Ultrasound (HFUS). In
addition, the company have established exclusive distribution agreement with the
Austrian manufacturer Agency for Medical Innovations (A.M.I.) with their product
portfolio in urology, coloproctology and urogynecology. Medistim already has the
rights for A.M.I. products in Norway and Denmark.  With a direct presence in
these three countries, Medistim is positioned to build a broader, Scandinavian
distribution business.

The new subsidiary, Medistim Sverige AB, is a subsidiary of Medistim Norge AS,
and 
will be managed by Ole Jørgen Robsrud, Managing Director for Norway and Denmark.


Medistim take the opportunity to acknowledge and appreciate the longstanding and
successful collaboration with Vingmed AB since 1994. Vingmed have established
the Medistim brand from scratch to become the recognized standard of care in
cardiac, vascular and transplant surgery in Sweden that it is today. 

"We are excited to take this step forward with our direct sales in Sweden,
strengthening our relationship with our customers and also opening up for
building a stronger Scandinavian third-party distribution business," says
Medistim President and CEO Kari E. Krogstad.  

About Medistim:
Medistim was established in 1984 and has a track record of profitable growth
over the past 20 years. The company is a pioneer within its segment and
continues to invest in new product development. Medistim has wholly owned
subsidiaries with sales organizations in the USA, Canada, China, Germany, the
UK, Spain, Denmark, Sweden and Norway, in addition to around 60 distributors in
Europe, Asia, the Middle East, Africa, and South America.

For more information, visit the Medistim home page: www.medistim.com

For more information, contact:
President and CEO, Kari E. Krogstad, Medistim ASA
Tel: + 47 918 38 110
Email: kari.krogstad@medistim.com

CFO, Thomas Jakobsen, Medistim ASA
Tel: + 47 906 59 940
Email: thomas.jakobsen@medistim.com